6th．Group award．Winner

Bora Pharmaceuticals, Taiwan's Leading CDMO: Model of Globalization for Taiwanese Biotech Industry Expanding from Local to Global Markets

Over the last decade, Bora Pharmaceuticals has swiftly grown through strategic mergers and acquisitions. Combined with solid integration and execution capabilities, Bora is able to become Taiwan's largest CDMO and compete with global players. This expansion has accelerated the development and distribution of new drugs at more accessible prices, invigorating the biopharmaceutical industry both in Taiwan and the world to bring forth more possibilities. Bora exemplifies through concrete actions that innovation is not only just crucial for boosting their competiveness as a company, but also a vital role in advancing enhancing human health and well-being.

• Date of announcement：2024/04/29
• Last updated： 2026/05/15
• Views：532